Contact Us
Global Next-Generation Oncology Devices And Solutions Market Report 2025

Next-Generation Oncology Devices And Solutions Global Market Report 2025 - By Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies), By Application (Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications), By End Use (Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses) - Market Size, Trends, And Global Forecast 2025-2034

Next-Generation Oncology Devices And Solutions Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : June 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Next-Generation Oncology Devices And Solutions Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Next-Generation Oncology Devices And Solutions Market?

Next-generation oncology devices and solutions refer to advanced technologies and tools designed to detect, diagnose, monitor, and treat various types of cancer with greater precision and speed. Their purpose is to enable personalized cancer care by leveraging innovations such as next-generation sequencing, digital pathology, and targeted therapies to improve patient outcomes.

The main cancer types addressed by next-generation oncology devices and solutions include breast cancer, cervical cancer, colorectal cancer, and lung cancer. Breast cancer is a disease in which cells in the breast grow uncontrollably, often forming a tumor that can be felt as a lump or detected through imaging. These solutions utilize technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), DNA microarrays, multiplexing, and other advanced methods and are applied in areas such as screening and early detection, prognostics and monitoring, therapy selection, and recurrence monitoring, among others. The key end users include hospitals and clinics, diagnostic laboratories, academic and research institutions, and others.

Next-Generation Oncology Devices And Solutions Market Size and growth rate 2025 to 2029: Graph

What Is The Next-Generation Oncology Devices And Solutions Market Size 2025 And Growth Rate?

The next-generation oncology devices and solutions market size has grown rapidly in recent years. It will grow from $13.90 billion in 2024 to $16.52 billion in 2025 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to rising cancer incidence globally, expansion of oncology research and clinical trials, growth of precision medicine, surge in hospital and diagnostic infrastructure, and rising awareness of early cancer screening.

What Is The Next-Generation Oncology Devices And Solutions Market Growth Forecast?

The next-generation oncology devices and solutions market size is expected to see rapid growth in the next few years. It will grow to $32.73 billion in 2029 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to the aging global population, rising investment in oncology startups, rising healthcare expenditures, rising demand for non-invasive or minimally invasive diagnostics, and the growth of healthcare infrastructures. Major trends in the forecast period include AI-powered diagnostic imaging, liquid biopsy advancements, personalized medicine platforms, wearable health monitoring devices, robotics, and minimally invasive surgical tools.

How Is The Next-Generation Oncology Devices And Solutions Market Segmented?

The next-generation oncology devices and solutions market covered in this report is segmented –

1) By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies

3) By Application: Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications

4) By End Use: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses

Subsegments:

1) By Breast Cancer: Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer

2) By Cervical Cancer: Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma

3) By Colorectal Cancer: Colon Cancer, Rectal Cancer, Metastatic Colorectal Cancer

4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma

What Is Driving The Next-Generation Oncology Devices And Solutions Market? Rising Cancer Prevalence Driving Demand For The Market Due To Growing Need For Early Detection And Personalized Care

The increasing prevalence of cancer is expected to propel the growth of the next-generation oncology devices and solutions market going forward. Cancer is a disease in which abnormal cells grow uncontrollably and can spread to other parts of the body, disrupting normal bodily functions. The rising prevalence of cancer is largely due to aging populations, as the risk of developing cancer increases with age. Next-generation oncology devices and solutions help manage the rising prevalence of cancer by enabling earlier detection, more precise diagnosis, and personalized treatment. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit organization, it is estimated that cancer will account for over 611,000 fatalities in the United States, equating to more than 1,600 cancer-related deaths daily. Therefore, the increasing prevalence of cancer will drive the growth of the next-generation oncology devices and solutions market.

Who Are The Major Players In The Global Next-Generation Oncology Devices And Solutions Market?

Major companies operating in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., Lucida Medical Ltd.

What Are The Key Trends Of The Global Next-Generation Oncology Devices And Solutions Market? Integrated DNA Technologies Unveils Innovative NGS Solution

Major companies in the next-generation oncology devices and solutions market are focusing on technological advancements such as next-generation sequencing (NGS) target enrichment solutions to improve the detection of rare genetic variants, enhance sequencing accuracy, and accelerate cancer diagnosis and treatment decisions. Next-generation sequencing (NGS) target enrichment solutions are techniques that selectively capture and concentrate specific regions of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) for sequencing, enabling more accurate and efficient analysis of genetic variants associated with diseases such as cancer. For instance, in April 2025, Integrated DNA Technologies (IDT), a US-based biotechnology company, unveiled the xGen Hybridization and Wash v3 Kit, a transformative hybridization capture solution designed to accelerate cancer research by streamlining next-generation sequencing (NGS) workflows. This innovative kit significantly reduces the hybridization time to just one hour, enabling researchers to complete sample preparation and proceed to sequencing within a single workday. By eliminating the need for heated buffers and cutting hands-on time by 20%, the solution is highly automation-friendly and well-suited for high-throughput applications.

What Are Latest Mergers And Acquisitions In The Next-Generation Oncology Devices And Solutions Market? Hologic Expands Breast Cancer Surgery Portfolio With Acquisition Of Endomag

In July 2024, Hologic, a US-based medical technology company, acquired Endomag for an undisclosed amount. With this acquisition, Hologic aims to strengthen its breast cancer surgery portfolio by integrating Endomag's innovative surgical guidance products for more precise and effective cancer care. Endomag is a UK-based medical device manufacturer specializing in surgical guidance products for breast cancer care.

What Is The Regional Outlook For The Global Next-Generation Oncology Devices And Solutions Market?

North America was the largest region in the next-generation oncology devices and solutions market in 2024. The regions covered in the next-generation oncology devices and solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the next-generation oncology devices and solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Next-Generation Oncology Devices And Solutions Market?

The next-generation oncology devices and solutions market consists of revenues earned by entities by providing services such as cancer genomic profiling and sequencing, personalized treatment planning, remote patient monitoring and tele-oncology, and early cancer detection and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation oncology devices and solutions market also includes sales of liquid biopsy kits, companion diagnostic tests, digital pathology systems, cancer biomarker detection assays, and targeted therapy monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Next-Generation Oncology Devices And Solutions Industry?

The next-generation oncology devices and solutions market research report is one of a series of new reports from The Business Research Company that provides next-generation oncology devices and solutions market statistics, including the next-generation oncology devices and solutions industry global market size, regional shares, competitors with the next-generation oncology devices and solutions market share, detailed next-generation oncology devices and solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the next-generation oncology devices and solutions industry. This next-generation oncology devices and solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Next Generation Oncology Devices And Solutions Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $16.52 billion
Revenue Forecast In 2034 $32.73 billion
Growth Rate CAGR of 18.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The next-generation oncology devices and solutions market covered in this report is segmented –
1) By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies
3) By Application: Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications
4) By End Use: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses Subsegments:
1) By Breast Cancer: Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
2) By Cervical Cancer: Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
3) By Colorectal Cancer: Colon Cancer, Rectal Cancer, Metastatic Colorectal Cancer
4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., Lucida Medical Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Next-Generation Oncology Devices And Solutions Market Characteristics

    3. Next-Generation Oncology Devices And Solutions Market Trends And Strategies

    4. Next-Generation Oncology Devices And Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global Next-Generation Oncology Devices And Solutions Growth Analysis And Strategic Analysis Framework

    5.1. Global Next-Generation Oncology Devices And Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Next-Generation Oncology Devices And Solutions Market Growth Rate Analysis

    5.4. Global Next-Generation Oncology Devices And Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Next-Generation Oncology Devices And Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Next-Generation Oncology Devices And Solutions Total Addressable Market (TAM)

    6. Next-Generation Oncology Devices And Solutions Market Segmentation

    6.1. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Breast Cancer

    Cervical Cancer

    Colorectal Cancer

    Lung Cancer

    6.2. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Next-Generation Sequencing (NGS)

    Polymerase Chain Reaction (PCR)

    DNA Microarrays

    Multiplexing

    Other Technologies

    6.3. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Screening And Early Detection

    Prognostics And Monitoring

    Therapy Selection

    Recurrence Monitoring

    Other Applications

    6.4. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals And Clinics

    Diagnostic laboratories

    Academic And Research Institutions

    Other End Users

    6.5. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Breast Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Invasive Ductal Carcinoma

    Invasive Lobular Carcinoma

    Triple-Negative Breast Cancer

    HER2-Positive Breast Cancer

    6.6. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Cervical Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Squamous Cell Carcinoma

    Adenocarcinoma

    Adenosquamous Carcinoma

    6.7. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Colon Cancer

    Rectal Cancer

    Metastatic Colorectal Cancer

    6.8. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Lung CancerX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Non-Small Cell Lung Cancer (NSCLC)

    Small Cell Lung Cancer (SCLC)

    Lung Adenocarcinoma

    Squamous Cell Lung Carcinoma

    7. Next-Generation Oncology Devices And Solutions Market Regional And Country Analysis

    7.1. Global Next-Generation Oncology Devices And Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Next-Generation Oncology Devices And Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Next-Generation Oncology Devices And Solutions Market

    8.1. Asia-Pacific Next-Generation Oncology Devices And Solutions Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Next-Generation Oncology Devices And Solutions Market

    9.1. China Next-Generation Oncology Devices And Solutions Market Overview

    9.2. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Next-Generation Oncology Devices And Solutions Market

    10.1. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Next-Generation Oncology Devices And Solutions Market

    11.1. Japan Next-Generation Oncology Devices And Solutions Market Overview

    11.2. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Next-Generation Oncology Devices And Solutions Market

    12.1. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Next-Generation Oncology Devices And Solutions Market

    13.1. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Next-Generation Oncology Devices And Solutions Market

    14.1. South Korea Next-Generation Oncology Devices And Solutions Market Overview

    14.2. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Next-Generation Oncology Devices And Solutions Market

    15.1. Western Europe Next-Generation Oncology Devices And Solutions Market Overview

    15.2. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Next-Generation Oncology Devices And Solutions Market

    16.1. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Next-Generation Oncology Devices And Solutions Market

    17.1. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Next-Generation Oncology Devices And Solutions Market

    18.1. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Next-Generation Oncology Devices And Solutions Market

    19.1. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Next-Generation Oncology Devices And Solutions Market

    20.1. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Next-Generation Oncology Devices And Solutions Market

    21.1. Eastern Europe Next-Generation Oncology Devices And Solutions Market Overview

    21.2. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Next-Generation Oncology Devices And Solutions Market

    22.1. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Next-Generation Oncology Devices And Solutions Market

    23.1. North America Next-Generation Oncology Devices And Solutions Market Overview

    23.2. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Next-Generation Oncology Devices And Solutions Market

    24.1. USA Next-Generation Oncology Devices And Solutions Market Overview

    24.2. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Next-Generation Oncology Devices And Solutions Market

    25.1. Canada Next-Generation Oncology Devices And Solutions Market Overview

    25.2. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Next-Generation Oncology Devices And Solutions Market

    26.1. South America Next-Generation Oncology Devices And Solutions Market Overview

    26.2. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Next-Generation Oncology Devices And Solutions Market

    27.1. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Next-Generation Oncology Devices And Solutions Market

    28.1. Middle East Next-Generation Oncology Devices And Solutions Market Overview

    28.2. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Next-Generation Oncology Devices And Solutions Market

    29.1. Africa Next-Generation Oncology Devices And Solutions Market Overview

    29.2. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Next-Generation Oncology Devices And Solutions Market Competitive Landscape And Company Profiles

    30.1. Next-Generation Oncology Devices And Solutions Market Competitive Landscape

    30.2. Next-Generation Oncology Devices And Solutions Market Company Profiles

    30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    31. Next-Generation Oncology Devices And Solutions Market Other Major And Innovative Companies

    31.1. Koninklijke Philips N.V.

    31.2. GE HealthCare Technologies Inc.

    31.3. Agilent Technologies Inc.

    31.4. Illumina Inc.

    31.5. Sysmex Corporation

    31.6. QIAGEN N.V.

    31.7. Exact Sciences Corporation

    31.8. Elekta AB

    31.9. Myriad Genetics Inc.

    31.10. Takara Bio USA Inc.

    31.11. NeoGenomics Inc.

    31.12. Guardant Health Inc.

    31.13. Accuray Incorporated

    31.14. SOPHiA GENETICS SA

    31.15. Paige.AI Inc.

    32. Global Next-Generation Oncology Devices And Solutions Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Next-Generation Oncology Devices And Solutions Market

    34. Recent Developments In The Next-Generation Oncology Devices And Solutions Market

    35. Next-Generation Oncology Devices And Solutions Market High Potential Countries, Segments and Strategies

    35.1 Next-Generation Oncology Devices And Solutions Market In 2029 - Countries Offering Most New Opportunities

    35.2 Next-Generation Oncology Devices And Solutions Market In 2029 - Segments Offering Most New Opportunities

    35.3 Next-Generation Oncology Devices And Solutions Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Next-Generation Oncology Devices And Solutions Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Breast Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Cervical Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Lung CancerX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Next-Generation Oncology Devices And Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Next-Generation Oncology Devices And Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Johnson & Johnson Services Inc. Financial Performance
  • Table 80: Siemens AG Financial Performance
  • Table 81: Merck & Co. Inc. Financial Performance
  • Table 82: Thermo Fisher Scientific Inc. Financial Performance
  • Table 83: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Next-Generation Oncology Devices And Solutions Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Breast Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Cervical Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Lung CancerX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Next-Generation Oncology Devices And Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Next-Generation Oncology Devices And Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Johnson & Johnson Services Inc. Financial Performance
  • Figure 80: Siemens AG Financial Performance
  • Figure 81: Merck & Co. Inc. Financial Performance
  • Figure 82: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 83: Novartis AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Next Generation Oncology Devices And Solutions market?

Next-generation oncology devices and solutions refer to advanced technologies and tools designed to detect, diagnose, monitor, and treat various types of cancer with greater precision and speed. Their purpose is to enable personalized cancer care by leveraging innovations such as next-generation sequencing, digital pathology, and targeted therapies to improve patient outcomes. For further insights on the Next Generation Oncology Devices And Solutions market, request a sample here

How will the Next Generation Oncology Devices And Solutions market drivers and restraints affect the market dynamics? What forces will shape the Next Generation Oncology Devices And Solutions industry going forward?

The Next Generation Oncology Devices And Solutions market major growth driver - Rising Cancer Prevalence Driving Demand For The Market Due To Growing Need For Early Detection And Personalized Care. For further insights on the Next Generation Oncology Devices And Solutions market, request a sample here

What is the forecast market size or the forecast market value of the Next Generation Oncology Devices And Solutions market?

The Next Generation Oncology Devices And Solutions market size has grown strongly in recent years. The next-generation oncology devices and solutions market size has grown rapidly in recent years. It will grow from $13.90 billion in 2024 to $16.52 billion in 2025 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to rising cancer incidence globally, expansion of oncology research and clinical trials, growth of precision medicine, surge in hospital and diagnostic infrastructure, and rising awareness of early cancer screening. The next-generation oncology devices and solutions market size is expected to see rapid growth in the next few years. It will grow to $32.73 billion in 2029 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to the aging global population, rising investment in oncology startups, rising healthcare expenditures, rising demand for non-invasive or minimally invasive diagnostics, and the growth of healthcare infrastructures. Major trends in the forecast period include AI-powered diagnostic imaging, liquid biopsy advancements, personalized medicine platforms, wearable health monitoring devices, robotics, and minimally invasive surgical tools. For further insights on the Next Generation Oncology Devices And Solutions market, request a sample here

How is the Next Generation Oncology Devices And Solutions market segmented?

The next-generation oncology devices and solutions market covered in this report is segmented –
1) By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies
3) By Application: Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications
4) By End Use: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses
Subsegments:
1) By Breast Cancer: Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
2) By Cervical Cancer: Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
3) By Colorectal Cancer: Colon Cancer, Rectal Cancer, Metastatic Colorectal Cancer
4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma For further insights on the Next Generation Oncology Devices And Solutions market,
request a sample here

Which region has the largest share of the Next Generation Oncology Devices And Solutions market? What are the other regions covered in the report?

North America was the largest region in the next-generation oncology devices and solutions market in 2024. The regions covered in the next-generation oncology devices and solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Next Generation Oncology Devices And Solutions market, request a sample here.

Who are the major players in the Next Generation Oncology Devices And Solutions market?

Major companies operating in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., Lucida Medical Ltd. . For further insights on the Next Generation Oncology Devices And Solutions market, request a sample here.

What are the key trends in the Next Generation Oncology Devices And Solutions market?

Major trends in the Next Generation Oncology Devices And Solutions market include Integrated DNA Technologies Unveils Innovative NGS Solution. For further insights on the Next Generation Oncology Devices And Solutions market, request a sample here.

What are the major opportunities in the Next Generation Oncology Devices And Solutions market? What are the strategies for the Next Generation Oncology Devices And Solutions market?

For detailed insights on the major opportunities and strategies in the Next Generation Oncology Devices And Solutions market, request a sample here.

How does the Next Generation Oncology Devices And Solutions market relate to the overall economy and other similar markets?

For detailed insights on Next Generation Oncology Devices And Solutions's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Next Generation Oncology Devices And Solutions industry?

For detailed insights on the mergers and acquisitions in the Next Generation Oncology Devices And Solutions industry, request a sample here.

What are the key dynamics influencing the Next Generation Oncology Devices And Solutions market growth? SWOT analysis of the Next Generation Oncology Devices And Solutions market.

For detailed insights on the key dynamics influencing the Next Generation Oncology Devices And Solutions market growth and SWOT analysis of the Next Generation Oncology Devices And Solutions industry, request a sample here.